Eye on the Eclipse: Demographic Trends in Solar Retinopathy From 2012 to 2024

Purpose: To characterize demographic, psychiatric, and retinal comorbidities associated with solar retinopathy in the United States from 2012 to 2024 and to evaluate incidence trends in relation to solar eclipse years. Methods: This retrospective, population-based cohort study was conducted using the TriNetX US Collaborative Research Network. Patients with newly diagnosed solar retinopathy ( International Classification of Diseases , 10th edition, code H31.02) were identified and included if they had a documented ophthalmology visit and retinal imaging. Annual incidence rates were compared between eclipse and non-eclipse years. Demographic characteristics and the prevalence of psychiatric disorders, substance use disorders, and concurrent retinal conditions were analyzed. Results: Among 1 042 995 patients, 555 were diagnosed with solar retinopathy. The mean annual incidence was 44.5 cases, with a peak observed in 2017 (71 cases). There was no statistically significant difference between eclipse years (51.5 cases/year) and non-eclipse years (37.3 cases/year; P = .062). The median age at diagnosis was 54.1 ± 21.3 years, and 59% of patients were men. Sixty-eight percent of individuals were White, 27% were Black, and 5% were Asian. Psychiatric comorbidities were common, with 32% diagnosed with anxiety disorders, 24% with major depressive episodes, and 10% with psychotic disorders. Substance use disorders were also observed, including nicotine dependence (18%) and cannabis-related disorders (6%). Concurrent retinal conditions included age-related macular degeneration (8%), hereditary retinal dystrophies (7%), and central serous chorioretinopathy (3%). There was no correlation between solar retinopathy incidence and geographic exposure to eclipse totality. Conclusions: The incidence of solar retinopathy remained low over the study period, with no significant increase during eclipse years. However, psychiatric and retinal comorbidities were prevalent among affected individuals. These findings highlight demographic and psychosocial disparities and support the need for targeted, culturally informed preventive education and eye safety initiatives before future eclipses.

Authors

Institutions

Publication Details

Journal
Journal of VitreoRetinal Diseases
Published
2026-05-18
DOI
https://doi.org/10.1177/24741264261447500
Primary Topic
Ophthalmology and Visual Impairment Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Eye on the Eclipse: Demographic Trends in Solar Retinopathy From 2012 to 2024

Ahmed F. Shakarchi, Qais A. Dihan, Alexis Brown, Nayef Alshammari et al.
Journal of VitreoRetinal Diseases
Ophthalmology and Visual Impairment Studies
article

Eye on the Eclipse: Demographic Trends in Solar Retinopathy From 2012 to 2024

Ahmed F. Shakarchi, Qais A. Dihan, Alexis Brown, Nayef Alshammari, Muhammad Z. Chauhan, Ahmed B. Sallam
article en

Abstract

Purpose: To characterize demographic, psychiatric, and retinal comorbidities associated with solar retinopathy in the United States from 2012 to 2024 and to evaluate incidence trends in relation to solar eclipse years. Methods: This retrospective, population-based cohort study was conducted using the TriNetX US Collaborative Research Network. Patients with newly diagnosed solar retinopathy ( International Classification of Diseases , 10th edition, code H31.02) were identified and included if they had a documented ophthalmology visit and retinal imaging. Annual incidence rates were compared between eclipse and non-eclipse years. Demographic characteristics and the prevalence of psychiatric disorders, substance use disorders, and concurrent retinal conditions were analyzed. Results: Among 1 042 995 patients, 555 were diagnosed with solar retinopathy. The mean annual incidence was 44.5 cases, with a peak observed in 2017 (71 cases). There was no statistically significant difference between eclipse years (51.5 cases/year) and non-eclipse years (37.3 cases/year; P = .062). The median age at diagnosis was 54.1 ± 21.3 years, and 59% of patients were men. Sixty-eight percent of individuals were White, 27% were Black, and 5% were Asian. Psychiatric comorbidities were common, with 32% diagnosed with anxiety disorders, 24% with major depressive episodes, and 10% with psychotic disorders. Substance use disorders were also observed, including nicotine dependence (18%) and cannabis-related disorders (6%). Concurrent retinal conditions included age-related macular degeneration (8%), hereditary retinal dystrophies (7%), and central serous chorioretinopathy (3%). There was no correlation between solar retinopathy incidence and geographic exposure to eclipse totality. Conclusions: The incidence of solar retinopathy remained low over the study period, with no significant increase during eclipse years. However, psychiatric and retinal comorbidities were prevalent among affected individuals. These findings highlight demographic and psychosocial disparities and support the need for targeted, culturally informed preventive education and eye safety initiatives before future eclipses.

Journal of VitreoRetinal Diseases
Ain Shams University (EG), University of Arkansas for Medical Sciences (US)
Good health and well-being
Openalex Percentile: Top 6%
Ophthalmology and Visual Impairment Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.